Vanda Pharmaceuticals
VNDA
VNDA
179 hedge funds and large institutions have $227M invested in Vanda Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 64 increasing their positions, 65 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
39% less capital invested
Capital invested by funds: $371M → $227M (-$144M)
58% less call options, than puts
Call options by funds: $35K | Put options by funds: $83K
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
179
Holding in Top 10
–
Calls
$35K
Puts
$83K
Top Buyers
| 1 | +$6.2M | |
| 2 | +$4.32M | |
| 3 | +$2.88M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$2.64M |
| 5 |
Morgan Stanley
New York
|
+$2.56M |
Top Sellers
| 1 | -$17.5M | |
| 2 | -$12M | |
| 3 | -$8.27M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.29M |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$1.99M |